Amgen Wins First EU Avastin Biosimilar Approval, But When Will It Launch?

 
• By Lucie Ellis-Taitt

Partners Amgen and Allergan have become the first biosimilar developers to win EU approval for a copycat version of Roche's Avastin; commercialization preparation is underway but predicting a launch date for the product is more complicated.

Fieldfare
Early bird gets the worm: Amgen/Allergan are first to win EU approval for Avastin biosimilar • Source: Shutterstocl

More from New Products

More from Scrip